CIK 0000310158
- Large accelerated filer
Merck & Co., Inc.
Sign in to watch- Ticker
- MRK
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NJ
- Entity type
- Operating
- EIN
- 221918501
- Phone
- +1 908-740-4000
- Business address
- 126 EAST LINCOLN AVENUE, P.O. BOX 2000, RAHWAY, NJ, 07065
- Former names
- Merck & Co. Inc., SCHERING PLOUGH CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $8,611,875
- in 1 filing
Net −$8,611,875. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-11-07 | FRAZIER KENNETH C Executive Chair | Exercise or conversion | +235,769 | 936,422.06 | ||
| 2022-11-07 | FRAZIER KENNETH C Executive Chair | Sale | −24,914 | $98.45 | $2.5M | 911,508.06 |
| 2022-11-07 | FRAZIER KENNETH C Executive Chair | Sale | −126,134 | $99.42 | $12.5M | 785,374.06 |
| 2022-11-07 | FRAZIER KENNETH C Executive Chair | Sale | −84,721 | $100.07 | $8.5M | 700,653.06 |
| 2022-11-07 | FRAZIER KENNETH C Executive Chair | Exercise or conversion · Stock Option (Right to Buy) | −235,769 | 0 | ||
| 2022-11-04 | FRAZIER KENNETH C Executive Chair | Exercise or conversion | +235,000 | 935,653.06 | ||
| 2022-11-04 | FRAZIER KENNETH C Executive Chair | Sale | −200,190 | $98.53 | $19.7M | 735,463.06 |
| 2022-11-04 | FRAZIER KENNETH C Executive Chair | Sale | −34,810 | $99.08 | $3.4M | 700,653.06 |
| 2022-11-04 | FRAZIER KENNETH C Executive Chair | Exercise or conversion · Stock Option (Right to Buy) | −235,000 | 235,769 | ||
| 2022-11-03 | FRAZIER KENNETH C Executive Chair | Exercise or conversion | +235,000 | 935,653.06 | ||
| 2022-11-03 | FRAZIER KENNETH C Executive Chair | Sale | −214,617 | $98.68 | $21.2M | 721,036.06 |
| 2022-11-03 | FRAZIER KENNETH C Executive Chair | Sale | −20,383 | $99.09 | $2.0M | 700,653.06 |
| 2022-11-03 | FRAZIER KENNETH C Executive Chair | Exercise or conversion · Stock Option (Right to Buy) | −235,000 | 470,769 | ||
| 2022-11-02 | FRAZIER KENNETH C Executive Chair | Exercise or conversion | +165,828 | 866,481.06 | ||
| 2022-11-02 | FRAZIER KENNETH C Executive Chair | Exercise or conversion | +134,172 | 1,000,653.06 | ||
| 2022-11-02 | FRAZIER KENNETH C Executive Chair | Sale | −205,661 | $99.68 | $20.5M | 794,992.06 |
| 2022-11-02 | FRAZIER KENNETH C Executive Chair | Sale | −94,339 | $100.40 | $9.5M | 700,653.06 |
| 2022-11-02 | FRAZIER KENNETH C Executive Chair | Exercise or conversion · Stock Option (Right to Buy) | −165,828 | 0 | ||
| 2022-11-02 | FRAZIER KENNETH C Executive Chair | Exercise or conversion · Stock Option (Right to Buy) | −134,172 | 705,769 | ||
| 2022-11-01 | FRAZIER KENNETH C Executive Chair | Exercise or conversion | +300,000 | 1,006,283.06 |
Page 1 of 3 · 43 trades